Vesselon Inc. develops patentable drugs using an FDA-approved, biophysically activatable lipid microsphere and self-assembling liposome platform. It produces unprecedented levels of efficacy by transforming how drugs are received and acted upon by tissues and cells. The platform can extend patents and create an endless stream of proprietary drugs. View Vesselon's digital Town Hall event at https://vesselon.com/townhall/.
Looking for a particular Vesselon employee's phone or email?
The Vesselon annual revenue was $4 million in 2026.
Clay Larsen is the President and CEO, Co-Founder of Vesselon.
2 people are employed at Vesselon.
Vesselon is based in Norwalk, Connecticut.
The NAICS codes for Vesselon are [54171, 541714, 541, 54, 5417].
The SIC codes for Vesselon are [87, 873].